| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.005 |